Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Blood|April 20, 2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
The Journal of Eukaryotic Microbiology|May 15, 2003
Freshwater foraminiferans revealed by analysis of environmental DNA samplesMaria Holzmann, Andrea Habura, Hannah Giles, et al.
Free Radical Biology & Medicine|July 23, 2014
Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formationIrundika H K Dias, Jayna Mistry, Shaun Fell, et al.
International Journal of Hematology|September 19, 2007
The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical studyZbigniew Rudzki, Tomasz Sacha, Anastazja Stój, et al.
Archivum Immunologiae Et Therapiae Experimentalis|December 2, 2008
Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndromeMaciej Siedlar, Zbigniew Rudzki, Magdalena Strach, et al.
Pathology|July 21, 2005
The prevalence of inherited thrombophilias in a Caucasian Australian populationCatherine S Gibson, Alastair H MacLennan, Zbigniew Rudzki, et al.
Przeglad Lekarski|April 24, 2012
[Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up]Ewa Ignacak, Alina Betkowska-Prokop, Marek Kuźniewski, et al.
The New Zealand Medical Journal|December 2, 2016
Efficacy and safety of TC-325 (HemosprayTM) for non-variceal upper gastrointestinal bleeding at Middlemore Hospital: the early New Zealand experienceHannah Giles, Dinesh Lal, Stephen Gerred, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Leukemia Research|August 19, 2003
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisisTomasz Sacha, Andreas Hochhaus, Benjamin Hanfstein, et al.
Pageof 9